Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Concert Pharmaceutic (NQ: CNCE )

3.890 USD +0.110 (+2.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 13, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 373,035
Open 3.810
Bid (Size) 3.690 (50)
Ask (Size) 4.000 (2)
Prev. Close 3.780
Today's Range 3.780 - 3.920
52wk Range 3.682 - 13.50
Shares Outstanding 32,173,778
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Concert Pharmaceuticals Reports First Quarter 2021 Financial Results
Concert reports financial results for the first quarter of 2021. 
From Business Wire News Releases
Concert Pharmaceuticals to Report First Quarter 2021 Results on May 4, 2021
The Company will host a conference call and webcast on May 4, 2021, to discuss its first quarter 2021 financial results and provide a business update. 
From Business Wire News Releases

Performance

YTD
-69.35%
-69.35%
1 Month
-15.80%
-15.80%
3 Month
-47.79%
-47.79%
6 Month
-64.76%
-64.76%
1 Year
-51.44%
-51.44%

More News

Read More
Analysts Anticipate IBB Will Reach $195
Tags ETFs
From ETF Channel
Concert Pharmaceuticals, Inc. (CNCE) Q1 2021 Earnings Call Transcript
Tags CNCE Market News
From Motley Fool
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
Tags CNTB ZEAL CAPR
From Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
Tags SONN News RMED
From Benzinga
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Tags KNSA NARI BTAI
From Benzinga
Stocks That Hit 52-Week Lows On Monday
Tags ATHX RLAY EDTK
From Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
Tags TARA BTAI NBSE
From Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
Tags CYAD EVFM VYGR
From Benzinga
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
Tags UTHR ADPT Biotech
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.